These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15345480)

  • 1. PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation.
    Nemoto S; Razeghi P; Ishiyama M; De Freitas G; Taegtmeyer H; Carabello BA
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H77-82. PubMed ID: 15345480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
    Pat B; Killingsworth C; Denney T; Zheng J; Powell P; Tillson M; Dillon AR; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2321-7. PubMed ID: 18849331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.
    Lie S; Hui M; McMillen IC; Muhlhausler BS; Posterino GS; Dunn SL; Wang KC; Botting KJ; Morrison JL
    Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(6):R429-37. PubMed ID: 24477540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
    Nemoto S; Hamawaki M; De Freitas G; Carabello BA
    J Am Coll Cardiol; 2002 Jul; 40(1):149-54. PubMed ID: 12103269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation.
    Urabe Y; Mann DL; Kent RL; Nakano K; Tomanek RJ; Carabello BA; Cooper G
    Circ Res; 1992 Jan; 70(1):131-47. PubMed ID: 1727683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
    Wölkart G; Schrammel A; Dörffel K; Haemmerle G; Zechner R; Mayer B
    Br J Pharmacol; 2012 Jan; 165(2):380-9. PubMed ID: 21585347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.
    Tsutsui H; Spinale FG; Nagatsu M; Schmid PG; Ishihara K; DeFreyte G; Cooper G; Carabello BA
    J Clin Invest; 1994 Jun; 93(6):2639-48. PubMed ID: 7911128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function.
    Nagatsu M; Zile MR; Tsutsui H; Schmid PG; DeFreyte G; Cooper G; Carabello BA
    Circulation; 1994 Feb; 89(2):818-26. PubMed ID: 8313571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell stabilization decreases cardiomyocyte and LV function in dogs with isolated mitral regurgitation.
    Pat B; Killingsworth C; Chen Y; Gladden JD; Walcott G; Powell PC; Denney T; Gupta H; Desai R; Tillson M; Dillon AR; Dell'italia LJ
    J Card Fail; 2010 Sep; 16(9):769-76. PubMed ID: 20797601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload.
    Nakano K; Swindle MM; Spinale F; Ishihara K; Kanazawa S; Smith A; Biederman RW; Clamp L; Hamada Y; Zile MR
    J Clin Invest; 1991 Jun; 87(6):2077-86. PubMed ID: 1828252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsion dynamics in the evolution from acute to chronic mitral regurgitation.
    Tibayan FA; Yun KL; Fann JI; Lai DT; Timek TA; Daughters GT; Ingels NB; Miller DC
    J Heart Valve Dis; 2002 Jan; 11(1):39-46; discussion 46. PubMed ID: 11858164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.
    Xu Y; Gen M; Lu L; Fox J; Weiss SO; Brown RD; Perlov D; Ahmad H; Zhu P; Greyson C; Long CS; Schwartz GG
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1314-23. PubMed ID: 15528232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced longitudinal contraction is associated with ischemic mitral regurgitation after posterior MI.
    Ishikawa K; Watanabe S; Hammoudi N; Aguero J; Bikou O; Fish K; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H322-H329. PubMed ID: 29101180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
    Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM
    Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus.
    Ishihara K; Zile MR; Kanazawa S; Tsutsui H; Urabe Y; DeFreyte G; Carabello BA
    Circulation; 1992 Nov; 86(5 Suppl):II16-25. PubMed ID: 1423995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.
    Perry GJ; Wei CC; Hankes GH; Dillon SR; Rynders P; Mukherjee R; Spinale FG; Dell'Italia LJ
    J Am Coll Cardiol; 2002 Apr; 39(8):1374-9. PubMed ID: 11955858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Hemodynamic Improvement after Transcatheter Mitral Valve Repair.
    Lavall D; Mehrer M; Schirmer SH; Reil JC; Wagenpfeil S; Böhm M; Laufs U
    J Am Soc Echocardiogr; 2018 Sep; 31(9):1013-1020. PubMed ID: 30176994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling.
    Foster E; Kwan D; Feldman T; Weissman NJ; Grayburn PA; Schwartz A; Rogers JH; Kar S; Rinaldi MJ; Fail PS; Hermiller J; Whitlow PL; Herrmann HC; Lim DS; Glower DD;
    Circ Cardiovasc Imaging; 2013 Jul; 6(4):522-30. PubMed ID: 23633132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.